Top Markets
Coin of the day
Aspire Biopharma Holdings, Inc. Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc.

ASBP
Rangering i aksjer #38702
Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise... Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship product, Instaprin, is an advanced sublingual aspirin formulation known for being soluble, pH neutral, and rapidly absorbed, making it effective for both cardiovascular emergencies and general pain management. The company is diligently developing a diverse pipeline of orally dissolving formulations. This includes a melatonin-based sleep aid, essential vitamins (D, E, and K), testosterone, and semaglutide. Furthermore, Aspire Biopharma is extending its sublingual development efforts to various therapeutic areas, such as anti-nausea treatments, antipsychotic medications, erectile dysfunction drugs, and seizure control therapies, among others. They are also exploring caffeine products, including a formulation for a single-dose sublingual pre-workout supplement. Established in 2021, the firm's main operational base is situated in Estero, Florida.
Aksjekurs
$7.37
Markedsverdi
$850.29K
Endring (1 dag)
3.66%
Endring (1 år)
-98.43%
Land
US
Handel Aspire Biopharma Holdings, Inc. (ASBP)

Kategori

Aksjeprishistorikk for Aspire Biopharma Holdings, Inc. (ASBP)
Høyeste sluttskurs: $7.39 den 2026-08-01

Laveste sluttskurs: $12.00K den 2022-04-01
Aksjeprishistorikk for Aspire Biopharma Holdings, Inc. fra 2022 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 27.39%
2025 -99.12%
2024 4.87%
2023 6.40%
2022 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$507.67 30.07%
US
$844.42 29.43%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE